Particle.news
Download on the App Store
9 ARTICLES
·
19h ago

HHS Pulls Funding From 22 mRNA Vaccine Programs

Kennedy says mRNA vaccines underperform against respiratory infections to justify redirecting funding toward broader, more established platforms.

El Departamento de Salud y Servicios Humanos de EEUU anunció la cancelación de 22 contratos para el desarrollo de vacunas de ARNm.
El presidente de Estados Unidos, Donald Trump, escucha al secretario de Salud y Servicios Humanos, Robert F. Kennedy Jr.
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. listens at a Make Oklahoma Healthy Again kickoff event at the Oklahoma State Capitol in Oklahoma City, Oklahoma, U.S. June 26, 2025. REUTERS/Nick Oxford
Empty vials of the Pfizer-BioNTech and Moderna vaccine are pictured in a vaccination center as part of the coronavirus disease (COVID-19) vaccination campaign in Geneva, Switzerland February 3, 2021. REUTERS/Denis Balibouse cesto tacho de basura vacunas

Overview

  • HHS rescinded funding for 22 BARDA-supported mRNA vaccine projects totaling about $500 million across major pharmaceutical and academic partners.
  • Kennedy said data show mRNA vaccines do not effectively protect against upper respiratory infections such as COVID-19 and influenza.
  • Some late-stage mRNA programs will remain funded to preserve previous investments and avoid waste of taxpayer dollars.
  • Redirected resources will support vaccine platforms with established safety records and transparent clinical and manufacturing data.
  • Former BARDA director Rick Bright and other scientists warn the decision could weaken U.S. preparedness for future pandemics.